The ethics of placebo in studies with fracture end points in osteoporosis. Stein CM, Ray WA (2010) N Engl J Med 363: 1367-70; discussion e21 Addressing the controversy: do bisphosphonates directly affect primary tumors? Sterling JA (2015) Cancer Discov 5: 14-5 Raloxifene improves skeletal properties in an animal model of cystic chronic kidney disease. Newman CL, Creecy A, Granke M, Nyman JS, Tian N, Hammond MA, Wallace JM, Brown DM, Chen N, Moe SM, Allen MR (2016) Kidney Int 89: 95-104 Repurposing the Nonsteroidal Anti-inflammatory Drug Diflunisal as an Osteoprotective, Antivirulence Therapy for Staphylococcus aureus Osteomyelitis. Hendrix AS, Spoonmore TJ, Wilde AD, Putnam NE, Hammer ND, Snyder DJ, Guelcher SA, Skaar EP, Cassat JE (2016) Antimicrob Agents Chemother 60: 5322-30 Identification of myeloid cell subsets in murine lungs using flow cytometry. Zaynagetdinov R, Sherrill TP, Kendall PL, Segal BH, Weller KP, Tighe RM, Blackwell TS (2013) Am J Respir Cell Mol Biol 49: 180-9 Clinician's Guide to Prevention and Treatment of Osteoporosis. Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R, National Osteoporosis Foundation (2014) Osteoporos Int 25: 2359-81 Calcium/vitamin D supplementation and coronary artery calcification in the Women's Health Initiative. Manson JE, Allison MA, Carr JJ, Langer RD, Cochrane BB, Hendrix SL, Hsia J, Hunt JR, Lewis CE, Margolis KL, Robinson JG, Rodabough RJ, Thomas AM, Women's Health Initiative and Women's Health Initiative-Coronary Artery Calcium Study Investigators (2010) Menopause 17: 683-91 Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. Harden RN, Oaklander AL, Burton AW, Perez RS, Richardson K, Swan M, Barthel J, Costa B, Graciosa JR, Bruehl S, Reflex Sympathetic Dystrophy Syndrome Association (2013) Pain Med 14: 180-229 Teriparatide is safe and effectively increases bone biomarkers in institutionalized individuals with osteoporosis. Ryder KM, Tanner SB, Carbone L, Williams JE, Taylor HM, Bush A, Pintea V, Watsky MA (2010) J Bone Miner Metab 28: 233-9 Duration of treatment in postmenopausal osteoporosis: how long to treat and what are the consequences of cessation of treatment? Laster AJ, Tanner SB (2011) Rheum Dis Clin North Am 37: 323-36, v Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. Bonnick SL, Silverman S, Tanner SB, Martens M, Bachmann G, Kohles JD, Civitelli R (2009) J Womens Health (Larchmt) 18: 935-43 Management of osteoporosis among home health and long-term care patients with a prior fracture. Warriner AH, Outman RC, Saag KG, Berry SD, Colón-Emeric C, Flood KL, Lyles KW, Tanner SB, Watts NB, Curtis JR (2009) South Med J 102: 397-404
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.